β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure*
暂无分享,去创建一个
N. Inestrosa | J. Parodi | C. Opazo | L. Aguayo | Nibaldo C. Inestrosa | Carlos Opazo | Fernando J. Sepúlveda | Luis G. Aguayo | Jorge Parodi | Jorge Roa | F. Sepúlveda | J. Roa
[1] E. Neher,et al. Presynaptic calcium and control of vesicle fusion , 2005, Current Opinion in Neurobiology.
[2] D. Selkoe,et al. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. , 2004, Protein and peptide letters.
[3] R. Kayed,et al. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis , 2006, Neurology.
[4] G. Lonart,et al. Deletion of synapsins I and II genes alters the size of vesicular pools and rabphilin phosphorylation , 2006, Brain Research.
[5] P. Robinson,et al. Ca2+ Influx Inhibits Dynamin and Arrests Synaptic Vesicle Endocytosis at the Active Zone , 2000, The Journal of Neuroscience.
[6] T. Südhof,et al. Role of calcium in neurotransmitter release evoked by α-latrotoxin or hypertonic sucrose , 2000, Neuroscience.
[7] C. Rabiner,et al. Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease , 2002, Neuroscience.
[8] E. Orlova,et al. α-Latrotoxin, Acting via Two Ca2+-dependent Pathways, Triggers Exocytosis of Two Pools of Synaptic Vesicles* , 2001, The Journal of Biological Chemistry.
[9] S. J. Smith,et al. The timing of synaptic vesicle endocytosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Kaye,et al. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. , 2005, Journal of Alzheimer's disease : JAD.
[11] G. Siegel,et al. Reversal of amyloid β toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody , 2002 .
[12] Adriana B Ferreira,et al. β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons* , 2006, Journal of Biological Chemistry.
[13] E. Rojas,et al. Ion channel formation by Alzheimer's disease amyloid β-peptide (Aβ40) in unilamellar liposomes is determined by anionic phospholipids , 2006, Peptides.
[14] M. Mattson. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.
[15] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[16] Adriana B Ferreira,et al. Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. , 2005, The Journal of biological chemistry.
[17] P. Vaughan,et al. Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones , 2001, Journal of neurochemistry.
[18] S. Davis,et al. Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits , 2001, The Journal of Neuroscience.
[19] Mark P Mattson,et al. Neuronal and glial calcium signaling in Alzheimer's disease. , 2003, Cell calcium.
[20] Stephen J. Smith,et al. Vesicle pool mobilization during action potential firing at hippocampal synapses , 1995, Neuron.
[21] Christian Rosenmund,et al. Definition of the Readily Releasable Pool of Vesicles at Hippocampal Synapses , 1996, Neuron.
[22] D. Selkoe,et al. Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation , 2004, Neuroscience Letters.
[23] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[24] N. Akaike,et al. Gramicidin perforated patch-clamp technique reveals glycine-gated outward chloride current in dissociated nucleus solitarii neurons of the rat. , 1994, Journal of neurophysiology.
[25] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[26] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[27] R. Anwyl,et al. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5 , 2004, The Journal of Neuroscience.
[28] Hai Lin,et al. Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Tapia,et al. Early expression of glycine and GABAA receptors in developing spinal cord neurons. Effects on neurite outgrowth , 2001, Neuroscience.
[30] W. Betz,et al. Synaptic vesicle pools , 2005, Nature Reviews Neuroscience.
[31] G. Konopka,et al. Mechanism and prevention of neurotoxicity caused by β-amyloid peptides: relation to Alzheimer's disease , 1997, Brain Research.
[32] G. Pappas,et al. Effect of hypertonic saline on quantal size and synaptic vesicles in identified neuromuscular junction of the frog , 1987, Neuroscience.
[33] Xudong Huang,et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.
[34] J. Díaz,et al. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers , 2007 .
[35] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[36] C. Masters,et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.
[37] H. Pollard,et al. Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity , 2006 .
[38] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[39] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[40] J. Qiao,et al. Amyloid β-protein fragment 31–35 forms ion channels in membrane patches excised from rat hippocampal neurons , 2001, Neuroscience.
[41] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[42] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.
[43] A. Campbell,et al. Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release. , 2004, Journal of Alzheimer's disease : JAD.
[44] Stephen J. Smith,et al. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons , 1993, Neuron.
[45] E. Rojas,et al. The Ability of Amyloid β‐Protein [AβP (1–40)] to Form Ca2+ Channels Provides a Mechanism for Neuronal Death in Alzheimer's Disease , 1994 .
[46] N. Arispe. Architecture of the Alzheimer’s AβP Ion Channel Pore , 2003, The Journal of Membrane Biology.
[47] N. Kato,et al. Mechanism of impairment of long-term potentiation by amyloid β is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons , 2005, Neuroscience Letters.
[48] R. Nicoll,et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Kourie,et al. Diversity of Amyloid β Protein Fragment [1–40]-Formed Channels , 2001, Cellular and Molecular Neurobiology.